Introduction
The Department of Pharmaceutics and Drug Regulatory Affairs are part of JKKMMRF'S ANNAI JKK SAMPOORANI AMMAL College of Pharmacy, Komarapalayam, collectively has 16 competent faculty members, where the quality and achievement of our faculty shows a commitment to excellence in academia, research and development is demonstrated through the productivity and success of our faculty and students.
Pharmaceutics is the discipline of pharmacy that deals with the science of dosage form design and embraces all facets of the process of turning a new chemical entity (NCE) into a medication that can be safely and effectively used by patients in the community.
The Drug Regulatory Affairs (DRA) refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation. The pharmaceutical law frame, guidelines covering Quality, Safety and Efficacy as well as Health Authorities' attitudes and requirements etc. have a great influence on the drug development process and the success of it. It professional plays an important role in every phase, from developing regulatory strategies following the discovery of a new chemical entity to planning post-marketing activities. The Department's mission is teaching and scientific research. The Department has remarkable research activities and excel in publishing wide range of research articles every year in well reputed peer reviewed indexed journals. Also, it has an excellent placement track record.
The Department has state-of- the art labs, modern facilities and well experienced staffs. It offers the students and research scholars to enrich their skill and knowledge in all disciplines from Preformulation studies, development of various dosage forms. Our department is responsible for teaching physical pharmacy, different pharmaceutical dosage forms, biopharmaceutics, pharmacokinetics, quality control, and manufacturing processes.
Vision & Mission
HOD Profile
PHARMACEUTICS & PHARMACEUTICAL REGULATORY AFFAIRS
Name : Dr.S.Chandra
Qualification : M.Pharm., Ph.D., D.Lit (London)
Department : Pharmaceutics
Designation : Professor and Head
Date of Joining : 18.12.2006
Dr.S.Chandra, M.Pharm., Ph.D., D.Lit (London)
Professor and Head
Field of Specialization |
Pharmaceutics |
Phone No. |
9789456750 |
|
|
Residential Address |
39/3A4., Easwari Garden, Kesavan Nagar., Kannakurichi P.O Salem. 636 008 |
Experience |
18 yrs |
Blood Group |
B+ Positive |
Area of Research
Ø Floating drug delivery system
Ø Nano particle
Ø Hydrogel
Ø Nano-Composite drug delivery.
International : 17
National : 41
UG : 17
PG : 51
Book Published : 5
Awards received : 4
Conference/ Workshop/ Symposium/ Seminar/FDP Attended : 63
Conference/ Workshop/ Symposium/ Seminar/FDP Conducted : 4
Resource Person in Conference/ Workshop/ Symposium/ Seminar/FDP : 1
Membership Details : APTI : TN/LMNo-354
IPGA : LMNo-428
IPA : LM.No-TN589
Staffs
Gallery
`
Area of Research
Pharmaceutical Research & Development Cell co-ordinates sponsored research, collaborative research and industrial consultancy projects at JKKMMRF’s Annai JKK Sampoorani Ammal college of Pharmacy. Through such projects, the Institute is strengthening the Research & Development capabilities of the faculty and students and participates in Industry relevant problem solving. Institute has experienced academicians and researchers from various R&D units of the country. In making our vision and mission a reality, the Institution has taken the initiative to promote innovation ideas of faculty and students and collaborate with Industries for mutual benefit. Committed to excellence in fundamental research as well as the development of innovative technologies for the future, the Institution offers a quality research training experience for its students.
The Institute maintains its relevance to world-class research by linking with industry and academia through local and international research networks. Preformulation studies , preparation , stability studies , evaluation of drugs using in laboratories as well as industries for sustained drug release , extended drug release , floating drug delivery system. More than 100 Various journals and articles published in various websites .
S.NO | Name of the Supervisor | University | Department | Research Area | E-Mail-ID |
---|---|---|---|---|---|
1 | Dr.S.Chandra | The Tamil Nadu Dr MGR Medical University | Pharmaceutics | Pharmaceutical science | chandrajkkm@gmail.com |
Events
Date | Name of the Add on course/ workshop/ seminar | Details of Resource person with designation | No. of participants |
---|---|---|---|
09/11/2021 | Artificial Neural Network as Helping Tool for Drug Formulation Strategies | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 341 |
Artificial Neural Networking in Controlled Drug Delivery | Dr.N.Senthilkumar, Principal Mr.R.Suresh, Assistant Professor | 347 | |
11/11/2021 | Neural Networks and Computational Complexity | Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor | 401 |
Artificial Neural Networks in the Process Analytical Technology of Pharmaceutical Manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant professor | 400 | |
17/11/2021 | Artificial Neural Networks innovative manufacturing in pharma sector | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 387 |
ANNs in upstream processes in API manufacturing | Dr.V.Suresh., Professor and HOD Dr.N.Senthilkumar, Principal | 384 | |
25/11/2021 | ANNs in downstream processes in pharma manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor | 371 |
Prospects of Artificial Neural Networks | Dr.V.Suresh, Professor and HOD Dr.N.Senthilkumar, Principal | 370 | |
29/11/2021 | Prediction of in vitro dissolution by neural network | Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor | 400 |
Application of Artificial Neural Networks in Modern Drug Discovery | Dr.V.Suresh, Professor and HOD Dr.N.Senthilkumar, Principal | 401 | |
07/02/2022 | Types of commonly uses simulations in formulation development | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 351 |
High Performance Computing and Network Simulation in formulation development | Dr.N.Senthilkumar, Principal Dr.v.Suresh, Professor and HOD | 350 | |
08/02/2022 | Problem-solving methodology in formulation development | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 371 |
Drug–Excipient Interaction and Incompatibilities using computer Simulation | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 370 | |
16/02/2022 | Ethics and Legal Protection of Uses of Computer Applications in Pharmaceutical Research | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 400 |
Dosage Form Design Uses of Computer Simulation | Dr.v.Suresh, Professor and HOD Dr.N.Senthilkumar, Principal | 400 | |
23/02/2022 | Computer Simulation in Biotechnology-based pharmaceutical production | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 387 |
Proteins and peptides drug delivery precise prediction using Computer Simulation | Dr.V.Suresh., Professor and HOD Dr.N.Senthilkumar, Principal | 388 | |
24/02/2022 | Design, discovery, and optimization of new chemical entities using Computer Simulation | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 402 |
Applications of Modelling and Simulation in pharmaceutical formulations | Dr.v.Suresh, Professor and HOD Dr.N.Senthilkumar, Principal | 401 | |
06/08/2022 | Pharmaceutical regulatory Affairs A prosperous pathway for next generation career | Dr. R. Arun , Director of Yarth life science | 567 |
Date | Name of the Add on course/ workshop/ seminar | Details of Resource person with designation | No. of participants |
---|---|---|---|
15/12/2020 | Optimal design concepts used in pharma industry | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 471 |
Guarantee the product quality through Optimal design | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 471 | |
16/12/2020 | Mathematical Models for Optimal design | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 468 |
Principles of Optimal Design | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 468 | |
17/12/2020 | Decision-Making and Design Optimization in pharma industry | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 471 |
Optimization Methods | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan., Professor | 471 | |
29/12/2020 | Robust Optimal Design and parameters | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 398 |
Design of complex systems through Optimal Design | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 398 | |
30/12/2020 | Trial-and-error modeling making in Pharma manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 471 |
Importance of optimal design in pharma industry | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 471 | |
01/03/2021 | Population Modeling in pharma Industry | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 384 |
Population Modeling Based Drug Development | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 384 | |
04/03/2021 | Modeling as a tool in drug development | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 470 |
Modeling and simulation | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 472 | |
10/03/2021 | Rational decisions regarding drug use and development using Population Modelling | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 384 |
Population Modelling in Biopharmaceutics applications | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 382 | |
18/03/2021 | The Components of Population Models | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 412 |
Estimation parameters in the model | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 412 | |
26/03/2021 | Graphical evaluations of the data in Population Models | Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor | 407 |
Software and Modeling Environment | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 408 |
Date | Name of the Add on course/ workshop/ seminar | Details of Resource person with designation | No. of participants |
---|---|---|---|
10/10/2019 | Automation technologies help in improving the efficiency of the pharmaceutical development and production | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 471 |
Advantages of process automation technologies in pharma | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 472 | |
16/10/2019 | Process Automation and Equipment | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 309 |
Improved accuracy, reliability, productivity through Automation Process | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 309 | |
17/10/2019 | Common Data Automation Techniques in Pharmaceutical manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 325 |
Types of automation systems | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 325 | |
29/10/2019 | The best automation testing tools | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 361 |
Artificial intelligence and automation | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 361 | |
30/10/2019 | Significance in enabling automation across pharma industries | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 381 |
The pros and cons of automation in pharma manufacturing | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 380 | |
13/02/2020 | Robotics Simulations in pharmaceutical industry | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 374 |
Robots currently used by the pharmaceutical industry | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 374 | |
18/02/2020 | R&D Tests and trials using robots | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 298 |
The evolution of robotics research | Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor | 300 | |
19/02//2020 | Service robotics to the pharmaceutical industry | Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor | 341 |
Challenges used robots in pharmaceutical industry | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 341 | |
26/02/2020 | Robots in Quality control operations | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 410 |
Robots in Testing and validation | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 410 | |
27/02/2020 | Robotics helps Regulatory compliance | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 374 |
Advantages and disadvantages of robotics in the pharmaceutical industry | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 371 | |
14/11/2019 | Scope of Pharma industry | Mr. T. Rajaram, Head of the Industry | 421 |
Date | Name of the Add on course/ workshop/ seminar | Details of Resource person with designation | No. of participants |
---|---|---|---|
04/06/2018 | Introduction on Automation in Pharmaceutical Profiling | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 298 |
Introduction on Drug Discovery Automation | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 300 | |
05/06/2018 | Selection of properties to profile during discovery | Dr.S.Chandra, Pofessor and HOD Mr.R.Suresh, Assistant Professor | 391 |
Automation of pharmaceutical property assays | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 391 | |
11/06/2018 | Application of Pharmaceutical Profiling Data in Drug Discovery | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 401 |
Data process, achieve retrieve and report | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 401 | |
18/06/2018 | High-capacity detectors in Pharmaceutical Profiling | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 352 |
Robotic liquid handler Automation in Pharmaceutical Profiling | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 355 | |
23/06/2018 | Pharmaceutical profiling in future directions | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 298 |
Crucial elements of automation for pharmaceutical profiling | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar., Principal | 300 | |
02/04/2018 | Introduction on Laboratory automation systems | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 426 |
Pharma Industry lab Automation and standard operating procedures | Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor | 426 | |
06/04/2018 | Laboratory automation system hardware and software | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 398 |
New and improved processes analysis of drugs | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant professor | 398 | |
10/04/2018 | Re-analytic, analytical, or post-analytical stages in lab automation | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 394 |
Instrumentation for lab automation processes | Dr.D.Krishnarajan., Professor Dr.N.Senthilkumar., Principal | 393 | |
17/04/2018 | Intelligent integration of robotics and laboratory automation software. | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 274 |
Automation is the Future of Lab Work | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 274 | |
18/04/2018 | Accelerating Drug Discover with Automation lab | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 398 |
Pros and cons in automation of laboratories | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 394 |
Date | Name of the Add on course/ workshop/ seminar | Details of Resource person with designation | No. of participants |
---|---|---|---|
21/08/2017 | Automation in pharmaceutical profiling and drug discovery | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 382 |
Pharma Industry Automation and compliance | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal Dr.S.Chandra, Professor and HOD | 387 | |
22/08/2017 | Artificial Intelligence technology used in the drug designing procedure | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 352 |
Pharma Manufacturing and Commercialization Softwares | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 350 | |
23/08/2017 | Automation in pharmaceutical manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant professor | 298 |
Automation is Changing the Global Pharma Industry | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 299 | |
14/09/2017 | Robotic process automation pros and cons in pharmaceutical manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 387 |
India Pharmaceutical Adopting Automation Technologies | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 390 | |
15/09/2017 | Automating Biopharma Manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 294 |
Robotic Pharmaceutical Manufacturing Processes for Improved Pharmaceutical Production | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 294 | |
02/11/2017 | Lab-scale testing of pharmaceutical materials and products | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 351 |
Formulation optimization are improved patient safety and compliance | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 357 | |
14/11/2017 | Necessity of Optimization Techniques in formulation development | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 418 |
Optimization process to identify and implement new methods in pharmaceutical manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 417 | |
15/11/2017 | Systematic design of experiments by modern approach. | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 402 |
Design of experiments applied in pharma industry to develop novel formulations | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 402 | |
24/11/2017 | Optimization problem in pharmaceutical manufacturing | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 398 |
Novel drug delivery design and development using design of experiments | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal | 398 | |
25/11/2017 | Computer simulations in optimization of formulation development | Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor | 452 |
Optimization problems in developing novel formulations | Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar., Principal | 457 | |
06/10/2018 | Recent trends and scope in pharmaceutics | Dr. K.Gowthamrajan , Professor and HOD Dr.V. Senthil, Professor Mr.T. Rajaram, Head of the industry | 780 |
PEO
M.PHARM (PHARMACEUTICS )
PROGRAMME EDUCATIONAL OUTCOMES (PEOs)
PEO - 1 |
To produce pharmacy post-graduates with strong fundamental concepts and high technical competence in pharmaceutical sciences and technology, who shall be able to use these tools in pharmaceutical industry and/or institutes where ever necessary for success. |
PEO - 2 |
To promote the development of trained human resource in Pharmaceutical Sciences for dissemination of quality education with highly professional and ethical attitude, strong communication skills, effective skills to work in a team with a multidisciplinary approach. |
PEO - 3 |
To generate potential knowledge pools with interpersonal and collaborative skills to identify, assess and formulate problems and execute the solution in closely related pharmaceutical industries. |
PROGRAMME SPECIFIC OUTCOMES (PSOs)
PSO - 1 |
Analyze, criticize, organize, improvise and manage documents, data and information related to pharmaceutical production process. |
PSO - 2 |
Execute team based research to implement innovative solutions in the area of formulation, quality assurance and technology transfer. |
PROGRAMME OUTCOMES (PO)
M.PHARM (PHARMACEUTICS )
PO - 1 |
Scientific knowledge: To apply the scientific and technological principles to design, develop effective pharmaceutical dosage forms and drug delivery systems for better therapeutic results. |
PO - 2 |
Technological applications: To utilize technical knowledge and identify any factors affecting the quality of pharmaceutical production. |
PO - 3 |
Modern tool usage: Learn, select, apply appropriate methods, procedures, resources, and modern pharmacy-related computing tools with an understanding of the limitations. |
PO - 4 |
Entrepreneurship: To understand the basics of establishing and management of pharmaceutical enterprise. |
PO - 5 |
Practical skills: To gain practical expertise in formulating and evaluating various novel drug release systems for minor ailments to major diseases. |
PO - 6 |
Applied science: To employ contemporary scientific knowledge viz., pharmacology, biotechnology for designing disease-centric pharmaceuticals. |
PO - 7 |
Computational and statistical methodologies: Applying and utilizing the statistical tools with the aid of computer software to optimize the formulations. |
PO - 8 |
Pharmaceutical ethics: To respect personal values and apply ethical principles in professional and social contexts. Demonstrate behavior that recognizes cultural, personal variability in values, communication and lifestyles. Use ethical frameworks; apply ethical principles while making decisions and take responsibility for the outcomes associated with the decisions. |
PO - 9 |
Environment and sustainability: To understand, protect and cooperate environmental concerns for sustaining biodiversity. |
PO - 10 |
Life-long learning: To develop the habit of updating knowledge from time to time to meet industrial demands and social needs for having a fruitful career. |
COURSE OUTCOMES
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I) |
|
MPH101T |
Modern Pharmaceutical Analytical Techniques |
CO - 1 |
Understand the basic instrumentation of HPTLC, HPLC, GC for identification, and characterization of compounds |
CO - 2 |
Understand the basic concept and instrumentation of Chromatographic techniques |
CO - 3 |
Understand the basic principles and instrumentation of fluorimeter and atomic absorption spectrometer |
CO - 4 |
Learn general principles and instrumentation of ion selective electrodes. |
CO - 5 |
Explain Instrumentation, separation and identification of compounds by electrophoresis technique |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I) |
|
MPH102T |
Drug Delivery System |
CO - 1 |
The various approaches for development of novel drug delivery systems. |
CO - 2 |
The criteria for selection of drugs and polymers for the development of delivering system |
CO - 3 |
Evaluate drug delivery systems for physic-chemical characteristics, in vitro and in vivo drug release |
CO - 4 |
Formulate and design controlled release and sustained release drug delivery systems. |
CO - 5 |
Conduct stability studies for dosage forms as per prescribed guidelines |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I) |
|
MPH103T |
Modern Pharmaceutics |
CO - 1 |
Perform the elements of pre formulation studies.
|
CO - 2 |
Understand the concept of Active Pharmaceutical Ingredients and Generic drug Product development |
CO - 3 |
Explain the Industrial Management and GMP Considerations. |
CO - 4 |
Understand the concept of Optimization Techniques & Pilot Plant Scale Up Techniques |
CO - 5 |
Describe about Stability Testing, sterilization process & packaging of dosage forms |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I) |
|
MPH104T |
Regulatory Affair |
CO - 1 |
Discuss the regulatory guidance and guidelines for filing and approval process. |
CO - 2 |
Categorize the preparation of dossiers and their submission to regulatory agencies in different countries |
CO - 3 |
Assess the post approval requirements for actives and drug products |
CO - 4 |
Describe the clinical trials requirements for approvals for conducting clinical trials |
CO - 5 |
Discuss the role of pharmacovigilance and the process of monitoring in clinical trials |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I) |
|
MPH105P |
Pharmaceutics Practical I |
CO - 1 |
Analysis of pharmacopoeial compounds and their formulations by UV Vis spectrophotometer |
CO - 2 |
Experiments based on HPLC |
CO - 3 |
To perform In-vitro dissolution profile of CR/ SR marketed formulation |
CO - 4 |
To carry out preformulation studies of tablets |
CO - 5 |
To plot Heckal plot, Higuchi and peppas plot and determine similarity factors. |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II) |
|
MPH201T |
Molecular Pharmaceutics (Nano Tech and Targeted DDS) |
CO - 1 |
Understand the basic instrumentation of HPTLC, HPLC, GC for identification, and characterization of compounds |
CO - 2 |
Understand the basic concept and instrumentation of Chromatographic techniques |
CO - 3 |
Understand the basic principles and instrumentation of fluorimeter and atomic absorption spectrometer |
CO - 4 |
Learn general principles and instrumentation of ion selective electrodes. |
CO - 5 |
Explain Instrumentation, separation and identification of compounds by electrophoresis technique |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II) |
|
MPH202T |
Advanced Biopharmaceutics & Pharmacokinetics |
CO - 1 |
Understand basic considerations of pharmacokinetic models. Understand different compartment model and non-compartment model |
CO - 2 |
Explain the design and evaluation of dosage regimens of the drugs using pharmacokinetic and biopharmaceutical parameters. |
CO - 3 |
Learn different types of drug interactions which alter the pharmacokinetics of such as drug-protein /drug-tissue binding interactions |
CO - 4 |
Elaborate design Bioavailability and Bioequivalence studies of new drugs or dosage forms |
CO - 5 |
Study the application of pharmacokinetics and pharmacodynamics of biotechnology drugs. |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II) |
|
MPH203T |
Computer Aided Drug Delivery System |
CO - 1 |
Know the basic computational modeling principles for drug disposition |
CO - 2 |
Learn computer aided biopharmaceutical characterization of drugs |
CO - 3 |
Learn computer simulation in pharmacokinetics and pharmacodynamics |
CO - 4 |
Study the use of computers in clinical development of drugs |
CO - 5 |
Understand the need of industrial automation by application of artificial intelligence, robotics and computational fluid dynamics |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II) |
|
MPH204T |
Cosmetic and Cosmeceuticals |
CO - 1 |
Describe the regulatory provisions related to the import and manufacture of cosmetics as per the Drugs and Cosmetics Act 1940 and the Rules 1945 |
CO - 2 |
Select key ingredients suitable in the formulation of various cosmetics |
CO - 3 |
Design cosmetics and cosmeceuticals with desired safety, stability and efficacy with a knowledge of the various technologies involved in their manufacture |
CO - 4 |
Design cosmeceuticals for sun protection, dry skin, acne, sun-protection, pigmentation, prickly heat, wrinkles, body odor. Dandruff, dental cavities, bleeding gums, mouth odor and sensitive teeth |
CO - 5 |
Select herbal ingredients in the formulation of cosmetics for hair care, skin care and oral care |
M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II) |
|
MPH205P |
Pharmaceutics Practical II |
CO - 1 |
To recall the basic techniques for preparation of microspheres, liposomes, niosomes and solid dispersions. |
CO - 2 |
To compare the dissolution studies of various marketed products. |
CO - 3 |
To develop various novel drug delivery systems. |
CO - 4 |
To test for drug binding characteristics, cell permeation and bioavailability of the formulations. |
CO - 5 |
To evaluate the novel drug delivery systems. |
M.PHARM - YEAR - II (SEMESTER - III) COMMON TO ALL BRANCHES |
|
MRM 301T |
Research Methodology and Biostatistics |
CO - 1 |
Students should understand a general definition of research design |
CO - 2 |
Students should be able to identify the overall process of designing a research study and the use of various statistical test involved |
CO - 3 |
Students should be familiar with human ethical issues in educational research, including those issues that arise in using quantitative and qualitative research |
CO - 4 |
Students should know the guidelines in performing animal study and maintenance of animal house. |
CO - 5 |
Students should be familiar with declaration of Helsinki |
M.PHARM - YEAR - II (SEMESTER - III & IV) COMMON TO ALL BRANCHES |
|
|
JOURNAL CLUB |
CO - 1 |
Able to collect relevant literature and critically evaluate them |
CO - 2 |
Learnt to make a PPT presentation scientifically and deliver the same |
CO - 3 |
Able to involve effectively in post presentation discussion |
M.PHARM - YEAR - II (SEMESTER - III & IV) COMMON TO ALL BRANCHES |
|
|
DISCUSSION / PRESENTATION (PROPOSAL PRESENTATION) |
CO - 1 |
Able to select research topic through literature review |
CO - 2 |
Able to design research methodology |
CO - 3 |
Able to Present the selected research proposal convincingly |
M.PHARM - YEAR - II (SEMESTER - III & IV) COMMON TO ALL BRANCHES |
|
|
RESEARCH WORK |
CO - 1 |
Able to carry out research work scientifically following research ethics
|
CO - 2 |
Able to collect date, interpret them using appropriate statistical tools and arrive at conclusion scientifically |
CO - 3 |
Able to document the research work in the form of thesis in an acceptable format |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS)
PROGRAMME EDUCATIONAL OUTCOMES (PEOs)
PEO - 1 |
To produce pharmacy post-graduates with strong fundamental concepts and high technical competence in pharmaceutical sciences and technology, who shall be able to use these tools in the pharmaceutical industry and/or institutes where ever necessary for success. |
PEO - 2 |
To promote the development of trained human resources in Pharmaceutical Sciences for dissemination of quality education with a highly professional and ethical attitude, strong communication skills, and effective skills to work in a team with a multidisciplinary approach. |
PEO - 3 |
To generate potential knowledge pools with interpersonal and collaborative skills to identify, assess and formulate problems and execute the solution in closely related pharmaceutical industries. |
PROGRAMME SPECIFIC OUTCOMES (PSOs)
PSO - 1 |
Identify and utilize the laws and regulations that apply to the development, testing, and production of new medical products, including medical devices, In-Vitro Diagnostics (IVDs), pharmaceuticals, biotechnology-derived therapeutics, and biologics. |
PSO - 2 |
Demonstrate the ability to investigate case studies related to various regulatory topics (e.g. regulatory submissions, product defect, clinical trials and quality assurance strategies etc.,). |
PROGRAMME OUTCOMES (PO)
M.PHARM (PHARMACEUTICAL REGUALTORY AFFAIRS)
PO - 1 |
To make available a pool of competent professionals in the area of Pharmaceutical Regulatory Affairs with fundamental knowledge on Various Good Regulatory Practices in the Healthcare and related industries |
PO - 2 |
Documentation and general principles involved in regulatory writing and submission to agencies. |
PO - 3 |
Audit, inspections, Quality management system and Product Life Cycle Management. |
PO - 4 |
Clinical drug development and research regulations in India, EU and US |
PO - 5 |
Regulations for Drugs, Cosmetics, Medical Devices, Herbals, Biologics, Food and Nutraceuticals in various countries like India, EU, US, Canada, Japan, ASEAN, etc., |
COURSE OUTCOMES
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - I) |
|
MRA101T |
Good Regulatory Practices |
CO - 1 |
The key elements of current Good Manufacturing Practices, Good Laboratory Practices, Good Automated Laboratory Practices, Good Documentation Practices and Good Regulatory Practices. |
CO - 2 |
The check lists for various Good Pharmaceutical Practices and Prepare SOPs for Good Pharmaceutical Practices |
CO - 3 |
Implement Good Pharmaceutical Practices in the Industries and Prepare for the Audit of the Pharmaceutical Industries. |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - I) |
|
MRA102T |
Documentation and Regulatory Writing |
CO - 1 |
Know the various documents pertaining to drugs in pharmaceutical industry |
CO - 2 |
Understand the basics of regulatory compilation |
CO - 3 |
Create and assemble the regulation submission as per the requirements of agencies |
CO - 4 |
Follow up the submissions and post approval document requirements |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - I) |
|
MRA103T |
Clinical Research Regulations |
CO - 1 |
History, origin and ethics of clinical and biomedical research and evaluation |
CO - 2 |
Clinical drug, medical device development process and different types and phases of clinical trials |
CO - 3 |
Regulatory requirements and guidance for conduct of clinical trials and research |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - I) |
|
MRA 104T |
Regulations and Legislation for Drugs & Cosmetics, Medical Devices, Biologicals & Herbals, and Food & Nutraceuticals In India and Intellectual Property Rights |
CO - 1 |
Know different Acts and guidelines that regulate Drugs & Cosmetics, Medical Devices, Biologicals & Herbals, and Food & Nutraceuticals industry in India. |
CO - 2 |
Understand the approval process and regulatory requirements for |
CO - 3 |
Drugs & Cosmetics, Medical Devices, Biologicals & Herbals, and Food& Nutraceuticals |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - I) |
|
MRA105P |
Regulatory Affairs Practical I |
CO - 1 |
Students will come to know the different competent regulatory authorities globally. |
CO - 2 |
Students be aware of technical aspects pertaining to the marketing authoritization application (MAA) |
CO - 3 |
The regulatory guidelines and directions framed by the regulatory authorities will be helpful to place the drug products in market for marketing approvals. |
CO - 4 |
Prepare and implement the check lists and SOPs for various Good Regulatory Practices. |
CO - 5 |
Implement Good Regulatory Practices in the Healthcare and related Industries. |
CO - 6 |
Prepare for the readiness and conduct of audits and inspections. |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - II) |
|
MRA201T |
Regulatory Aspects of Drugs & Cosmetics |
CO - 1 |
Process of drug discovery and development and generic product development |
CO - 2 |
regulatory approval process and registration procedures for API and drug products in US, EU |
CO - 3 |
Cosmetics regulations in regulated and semi-regulated countries |
CO - 4 |
A comparative study of India with other global regulated markets |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - II) |
|
MRA202T |
Regulatory Aspects of Herbal & Biologicals |
CO - 1 |
Know the regulatory Requirements for Biologics and Vaccines |
CO - 2 |
Understand the regulation for newly developed biologics and biosimilars |
CO - 3 |
Know the pre-clinical and clinical development considerations of biologics |
CO - 4 |
Understand the Regulatory Requirements of Blood and/or Its Components Including Blood Products and label requirements |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - II) |
|
MRA203T |
Regulatory Aspects of Medical Devices |
CO - 1 |
Basics of medical devices and IVDs, process of development, ethical and quality considerations harmonization initiatives for approval and marketing of medical devices and IVDs regulatory approval process for medical devices and IVDs in India, US, Canada, EU, Japan and ASEAN clinical evaluation and investigation of medical devices and IVDs |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - II) |
|
MRA204T |
Regulatory Aspects of Food & Nutraceuticals |
CO - 1 |
Know the regulatory Requirements for nutraceuticals. |
CO - 2 |
Understand the regulation for registration and labeling of nutraceuticals and food supplements in India, USA and Europe. |
M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS ) YEAR - I (SEMESTER - II) |
|
MRA205P |
Regulatory Affairs Practical II |
CO - 1 |
The clear information about the patent laws, intellectual property rights and drug regulation in India and abroad is gained by the students |
CO - 2 |
Upon completion of the course the student shall be able to Know the various documents pertaining to drugs in pharmaceutical industry |
CO - 3 |
Understand the basics of regulatory compilation |
CO - 4 |
Create and assemble the regulation submission as per the requirements of agencies |
CO - 5 |
Follow up the submissions and post approval document requirements |
PHARM.D
PROGRAMME EDUCATIONAL OUTCOMES (PEOs)
PEO - 1 |
The student will possess professional knowledge of pharmaceutical sciences and technology applicable in pharmaceutical, healthcare industry, community pharmacy and academia as per the requirement. |
PEO - 2 |
With the grooming and knowledge gained, the student will play a major role as professional Pharmacist in the health care team and participate in implementation of various health programs at large. |
PEO - 3 |
The student will inculcate the urge for lifelong learning and up - gradation to meet the needs of the profession and society. |
PROGRAMME SPECIFIC OUTCOMES (PSOs)
PSO - 1 |
Apply and assess the literature and other research resources to provide evidence-based drug information that meets the needs of patients and other health care providers. |
PSO - 2 |
Discuss how patients and care givers can obtain the most cost-efficient medications and related pharmaceuticals per patient-specific health insurance coverage options. |
PROGRAMME OUTCOMES (PO)
PHARM D
PO - 1 |
Pharmacy Knowledge: Possess knowledge and comprehension of the core and basic knowledge associated with the profession of pharmacy, including biomedical sciences; pharmaceutical sciences; behavioral, social, and administrative pharmacy sciences; and manufacturing practices. |
PO - 2 |
Planning Abilities: Demonstrate effective planning abilities including time management, resource management, delegation skills and organizational skills. Develop and implement plans and organize work to meet deadlines. |
PO - 3 |
Problem analysis: Utilize the principles of scientific enquiry, thinking analytically, clearly and critically, while solving problems and making decisions during daily practice. Find, analyze, evaluate and apply information systematically and shall make defensible decisions. |
PO - 4 |
Modern tool us age: Learn, select, and apply appropriate methods and procedures, resources, and modern pharmacy-related computing tools with an understanding of the limitations. |
PO - 5 |
Leadership skills: Understand and consider the human reaction to change, motivation issues, leadership and team-building when planning changes required for fulfillment of practice, professional and societal responsibilities. Assume participatory roles as responsible citizens or leadership roles when appropriate to facilitate improvement in health and well-being. |
PO - 6 |
Professional Identity: Understand, analyze and communicate the value of their professional roles in society (e.g. health care professionals, promoters of health, educators, managers, employers, employees) |
PO - 7 |
Pharmaceutical Ethics: Honor personal values and apply ethical principles in professional and social contexts. Demonstrate behavior that recognizes cultural and personal variability in values, communication and lifestyles. Use ethical frameworks; apply ethical principles while making decisions and take responsibility for the outcomes associated with the decisions. |
PO - 8 |
Communication: Communicate effectively with the pharmacy community and with society at large, such as, being able to comprehend and write effective reports, make effective presentations and documentation, and give and receive clear instructions. |
PO - 9 |
The Pharmacist and society: Apply reasoning informed by the contextual knowledge to assess societal, health, safety and legal issues and the consequent responsibilities relevant to the professional pharmacy practice. |
COURSE OUTCOMES
PHARM D - Ist YEAR |
|
1.2 |
Pharmaceutics (THEORY) |
CO - 1 |
Understand the basics of different dosage forms. |
CO - 2 |
Understand the professional way of handling the prescription |
CO - 3 |
Prepare various conventional dosage forms |
CO - 4 |
Develop a clear idea about Pharmaceutical incompatibility and different pharmaceutical calculations in pharmacy. |
CO - 5 |
Predict the instability problems in heterogeneous dosage forms |
|
|
1.2 |
Pharmaceutics (PRACTICAL) |
CO - 1 |
Understand the professional way of preparing a prescription |
CO - 2 |
Prepare various liquid dosage forms |
CO - 3 |
Prepare various solid dosage forms |
CO - 4 |
Acquire the knowledge of using equipment’s in pharmaceutical industry |
CO - 5 |
Develop a clear idea about Pharmaceutical incompatibility and different pharmaceutical calculations in pharmacy. |
PHARM D – Ist YEAR |
|
1.6 |
Remedial Mathematics (THEORY) |
CO – 1 |
To understand the role of mathematics in pharmacy |
CO – 2 |
To know about theory and their application in pharmacy |
CO – 3 |
To relate the mathematical tools in the wide professional views and solve problems of trigonometry, calculus and matrices. |
CO – 4 |
To solve the different types of problems by applying theory. |
CO – 5 |
To adopt both conventional and creative techniques to the solutions of mathematical problems. |
CO – 6 |
Apply the range of techniques effectively to solve problems including theory deduction, approximation and simulation. |
CO – 7 |
Gain knowledge on how to solve different types of problems by applying theory and applications of mathematics in pharmacy |
PHARM D - 2nd YEAR |
|
2.2 |
Pharmaceutical Microbiology (THEORY) |
CO - 1 |
Know the anatomy, identification, growth factors and sterilization of microorganisms; |
CO - 2 |
Know the mode of transmission of disease causing microorganism, symptoms of disease, and treatment aspect; |
CO - 3 |
Do cultivation and identification of the microorganisms in the laboratory |
CO - 4 |
Do identification of diseases by performing the diagnostic tests |
CO - 5 |
Appreciate the behavior of motility and behavioral characteristics of microorganisms |
|
|
2.2 |
Pharmaceutical Microbiology (PRACTICAL) |
CO - 1 |
Discuss about the instruments used in experimental microbiology |
CO - 2 |
Understand the sterilization methods followed in laboratory. |
CO - 3 |
Ability to perform the staining techniques used in microbiology. |
CO - 4 |
Carry out assay of different antibiotics |
CO - 5 |
Execute different sterility tests and bacteriological analysis of water |
PHARM D - 3rd YEAR |
|
3.4 |
Pharmaceutical Jurisprudence (THEORY) |
CO - 1 |
Practice the Professional ethics |
CO - 2 |
Understand the various concepts of the pharmaceutical legislation in India |
CO - 3 |
Know the various parameters in the Drug and Cosmetic Act and rules |
CO - 4 |
Know the Drug policy, DPCO, Patent and design act |
CO - 5 |
Be able to understand the concepts of Dangerous Drugs Act, Pharmacy Act and Excise duties Act. |
PHARM D - 3rd YEAR |
|
3.6 |
Pharmaceutical Formulations (THEORY) |
CO - 1 |
Acquire knowledge about the various pharmaceutical dosage forms and their manufacturing techniques |
CO - 2 |
Discover various formulation considerations in development of pharmaceutical dosage forms like tablets, capsules. |
CO - 3 |
Understand the quality control tests for the dosage forms. |
CO - 4 |
Detail on parenterals, stringent procedures in the preparation and its evaluation. |
CO - 5 |
Understand clearly about packaging and cosmetic preparations. |
|
|
3.6 |
Pharmaceutical Formulations (PRACTICAL) |
CO - 1 |
Manufacture of Tablets |
CO - 2 |
Understand the strict formulation considerations in parenteral and ophthalmic preparations. |
CO - 3 |
Demonstrate the evaluations of different packaging materials in pharmaceutical industry. |
CO - 4 |
Demonstrate the manufacturing of capsules. |
CO - 5 |
Preparation of various cosmetic formulations. |
PHARM D - 4th YEAR |
|
4.4 |
Bio Statistics & Research Methodology (THEORY) |
CO - 1 |
Learn general research methodology |
CO - 2 |
Understand the basic concepts of biostatistics |
CO - 3 |
Learn different parametric and non-parametric tests |
CO - 4 |
Understand the functions of ethics committees in medical research |
CO - 5 |
Develop the ability to apply the methods while working on a research project work |
CO - 6 |
Describe the appropriate statistical methods required for a particular research design. |
CO - 7 |
Choose the appropriate research design and develop appropriate research hypothesis for a research project. |
CO - 8 |
Develop a appropriate framework for research studies. |
PHARM D - 4th YEAR |
|
4.5 |
Biopharmaceutics & Pharmacokinetics (THEORY) |
CO - 1 |
Understand the basic concepts in biopharmaceutics and pharmacokinetics and their significance |
CO - 2 |
Explain the use of plasma drug concentration-time data to calculate the pharmacokinetic parameters |
CO - 3 |
Understand the concepts of bioavailability and bioequivalence of drug products and their significance |
CO - 4 |
Demonstrate a clear information on compartmental models and methods to assess the models |
CO - 5 |
Understand various pharmacokinetic parameters, their significance & applications. |
4.5 |
Biopharmaceutics & Pharmacokinetics (PRACTICAL) |
CO - 1 |
Explain the use of plasma drug concentration-time data to calculate the pharmacokinetic parameters |
CO - 2 |
Understand the concepts of bioavailability and bioequivalence of drug products and their significance |
CO - 3 |
Understand various pharmacokinetic parameters, their significance & applications |
CO - 4 |
Demonstrate a clear information on compartmental models and methods to assess the models. |
CO - 5 |
Describe the kinetics of drug absorption, distribution, metabolism, excretion, elimination. |
B.PHARM
PROGRAMME EDUCATIONAL OUTCOMES (PEOs)
PEO - 1 |
To produce pharmacy graduates with strong basics and high technical knowledge to cater the various areas of Pharmaceutical Industry. |
PEO - 2 |
Graduates will be able to discharge the responsibilities of pharmacist with adequate understanding of supportive area as needed in this multidisciplinary area of health care system. |
PEO - 3 |
Pharmacists will be able to a part of the team to communicate well with other professionals in providing medicines needed to society with standards, professional ethics and social responsibilities. |
PROGRAMME SPECIFIC OUTCOMES (PSOs)
PSO - 1 |
Apply the knowledge of pharmaceutical and allied sciences in design, manufacture and evaluation of drug delivery systems including cosmetics. |
PSO - 2 |
Appreciate the mechanism of action of drugs including their kinetics and adverse actions. Be able to do basic evaluation of bioactivity of drugs in in - silico models. |
PROGRAMME OUTCOMES (PO)
B.PHARM
PO - 1 |
Domain Knowledge: Demonstrate comprehension of basic principles of pharmaceutical and allied sciences in all pertinent scenarios. Exhibit skills associated with the profession of pharmacy, pharmaceutical manufacturing practices and quality control. |
PO - 2 |
Problem analysis: Use domain knowledge, analytical and critical thinking for solving problems and taking decisions during everyday practice in profession, industry and all work environment. |
PO - 3 |
Research and Development: Exhibit knowledge from his major domain in problem identification, critical thinking, analysis and providing solutions to pharmaceutical and allied technology disciplines. |
PO - 4 |
Modern tools usage: Demonstrate an ability to handle/use various tools, apparatus, instrument, equipment or machinery pertinent to the pharmaceutical domain with practical knowledge on standard operating procedures and safety aspects. |
PO - 5 |
The Pharmacist and Society: Use contextual knowledge – informed reasoning to understand medical prescription, perform patient counseling. Recognize the necessity to engage in independent and life-long learning. |
PO - 6 |
Environment and sustainability: Demonstrate knowledge and responsibility while handling pharmaceutical techniques/ processes that have social and environmental impacts and promote sustainable development. |
PO - 7 |
Ethics: Demonstrate exemplary professional, ethical, and legal behaviors in accordance with all drug, pharmaceutical, and pharmacy-related central, state laws and regulations. |
PO - 8 |
Individual and Team skills: Function effectively as an individual member or leader in different teams and multidisciplinary settings. Assume a participatory or lead role in an organization’s planning and execution of transformational projects to enhance its prospects. |
PO - 9 |
Communication: Communicate effectively with the pharmaceutical scientific community, work- force and with society at large, with abilities to comprehend and write effective reports, make effective presentations and documentation. |
PO - 10 |
Project management abilities: Demonstrate effective delegation and organizational skills. Organize work with necessary planning and execution to meet deadlines. Demonstrate knowledge and understanding of pharmaceutical, legal processes and apply them in project management. |
COURSE OUTCOMES
B.PHARM YEAR - I (SEMESTER - I) |
|
BP103T |
Pharmaceutics I – Theory |
CO - 1 |
Explain development and latest edition of Pharmacopoeia and other compendia
|
CO - 2 |
Describe various routes of drug administration, concept of dosage forms, and formulation of solution.
|
CO - 3 |
Describe various preformulation parameters and classify excipients with its examples |
CO - 4 |
Elaborate different pharmaceutical calculation involved in formulation |
CO - 5 |
Explain type of Pharmaceutical incompatibility |
BP109P |
Pharmaceutics I – Practical |
CO - 1 |
Demonstrate skill of preparation and evaluation of monophasic liquids. |
CO - 2 |
Demonstrate skill of preparation and evaluation of Biphasic liquids. |
CO - 3 |
Explain principles of formulation and evaluation of powder preparations. |
CO - 4 |
Perform pharmaceutical calculations |
CO - 5 |
Draw the labels in prescribed manner including all the component/parts |
B.PHARM YEAR - I (SEMESTER - I) |
|
BP105T |
Communication skills – Theory |
CO - 1 |
Understand the behavioral needs for a Pharmacist to function effectively in the areas of pharmaceutical operation |
CO - 2 |
Communicate effectively (Verbal and Non-Verbal) |
CO - 3 |
Effectively manage the team as a team player |
CO - 4 |
Develop interview skills |
CO - 5 |
Develop Leadership qualities and essentials |
<script src="//cdn.public.n1ed.com/ZwQM
B.PHARM YEAR - I (SEMESTER - I) |
|
BP105T |
Communication skills – Theory |
CO - 1 |
Understand the behavioral needs for a Pharmacist to function effectively in the areas of pharmaceutical operation |
CO - 2 |
Communicate effectively (Verbal and Non-Verbal) |
CO - 3 |
Effectively manage the team as a team player |
CO - 4 |
Develop interview skills |
CO - 5 |
Develop Leadership qualities and essentials
|
BP111P |
Communication skills – Practical |
CO - 1 |
To learn the behavior needs for the pharmacist to function effectively in the areas of pharmaceutical operation. |
CO - 2 |
To be effective verbal and Non-Verbal communication |
CO - 3 |
To develop the communication skills to effectively mange the team as team player |
CO - 4 |
To Communicate in Interview effectively. |
CO - 5 |
To know and develop the essential qualities of good Leader. |
B.PHARM YEAR - I (SEMESTER - I) |
|
BP106RMT |
Remedial Mathematics – Theory |
CO - 1 |
To understand the role of mathematics in pharmacy. |
CO - 2 |
To know about theory and their application in pharmacy. |
CO - 3 |
To relate the mathematical tools in the wide professional views and solve problems of trigonometry, calculus and matrices. |
CO - 4 |
To solve the different types of problems by applying theory. |
CO - 5 |
To adopt both conventional and creative techniques to the solutions of mathematical problems. |
CO - 6 |
Apply the range of techniques effectively to solve problems including theory deduction, approximation and simulation. |
CO - 7 |
Gain knowledge on how to solve different types of problems by applying theory and applications of mathematics in pharmacy. |
B.PHARM - YEAR - I (SEMESTER - II) |
|
BP205T |
Computer Applications in Pharmacy – Theory |
CO - 1 |
Apply the knowledge of mathematics and computing fundamentals to pharmaceutical applications for any given requirement. |
CO - 2 |
Design and develop solutions to analyze pharmaceutical problems using computers. |
CO - 3 |
Integrate and apply efficiently the contemporary IT tools to all pharmaceutical related activities. |
CO - 4 |
Know the various databases in pharmacy |
|
|
BP210P |
Computer Applications in Pharmacy – Practical |
CO - 1 |
Retrieve the information of a drug and its adverse effect using online tools. |
CO - 2 |
Able to acquire knowledge of computer application in clinical studies and use of databases. |
CO - 3 |
Work with MS Access. |
CO - 4 |
Exporting Tables, Queries, Forms and Report to web pages and HTML |
CO - 5 |
Creating labels, databases regarding patient information. |
B.PHARM - YEAR - I (SEMESTER - II) |
|
BP206T |
Environmental sciences – Theory |
CO - 1 |
Analyze the interrelationship between living organism and environment. |
CO - 2 |
Understand the importance of environment by assessing its impact on the human world. |
CO - 3 |
Enrich the knowledge on themes of biodiversity, natural resources, pollution control and waste management. |
CO - 4 |
Understand the constitutional protection given for environment. |
CO - 5 |
An Environmental Studies major will be able to recognize the physical, chemical, and biological components of the earth’s systems and show how they function |
B.PHARM - YEAR - II (SEMESTER - III) |
|
BP302T |
Physical Pharmaceutics I – Theory |
CO - 1 |
Investigate and apply various theories, laws and equations related to different states of matter |
CO - 2 |
Understand the mechanisms of solute solvent interactions |
CO - 3 |
Understand the concept of surface and interfacial tension and their applications in pharmaceuticals. |
CO - 4 |
Understand the various intermolecular forces involved in the formation of complexes and its applications |
CO - 5 |
Understanding and applying the knowledge of Buffers and Isotonic solutions in the formulation and development of various dosage form. |
BP306P |
Physical Pharmaceutics I – Practical |
CO - 1 |
Calculate surface tension of given liquid, critical micelle concentration and HLB value of given surfactant |
CO - 2 |
Determine partition coefficient of drug in O/W system and understanding its importance in formulation development. |
CO - 3 |
Understanding the phase rule and determining % composition of NaCl in a solution using phenol-water system by CST method. |
CO - 4 |
Determining pKa value of drug substances using Half Neutralization/ Henderson Hasselbalch equation and applying this knowledge in formulating suitable drug delivery system to improve bioavailability |
CO - 5 |
Determination of stability constant and donor acceptor ratio of various complexes by pH titration and solubility method. |
B.PHARM - YEAR - II (SEMESTER - III) |
|
BP303T |
Pharmaceutical Microbiology – Theory |
CO - 1 |
Explain methods of identification, cultivation and preservation of various microorganisms |
CO - 2 |
Understand the effectiveness of sterilization processes implemented in pharmaceutical industry. |
CO - 3 |
Understand mode of action disinfectants, sterility testing & microbiological assays of various pharmaceutical products. |
CO - 4 |
Summarize types of microbial spoilages & preservation of pharmaceutical products. |
CO - 5 |
Outline the cell culture technology and its applications in pharmaceutical industries. |
BP307P |
Pharmaceutical Microbiology – Practical |
CO - 1 |
Apply the knowledge in operating various instruments & scientific techniques. |
CO - 2 |
Demonstrate various staining procedures for studying morphology of bacteria & observe the motility of bacteria. |
CO - 3 |
Isolate bacteria by streak plate technique & count them by pour plate technique |
CO - 4 |
Carry out microbiological standardization of Pharmaceuticals |
CO - 5 |
Perform bacteriological analysis of water and sterility testing of pharmaceutical products. |
B.PHARM - YEAR - II (SEMESTER - III) |
|
BP304T |
Pharmaceutical Engineering – Theory |
CO - 1 |
Understand the various laws, mechanisms of unit operations. |
CO - 2 |
Understand the material handling techniques. |
CO - 3 |
Explain the various processes involved in Pharmaceutical manufacturing process. |
CO - 4 |
Understand the concepts of heat transfer and fluid flow. |
CO - 5 |
Describe various preventive methods used for corrosion control in Pharmaceutical industries |
BP 308P |
Pharmaceutical Engineering –Practical |
CO - 1 |
To understand the principle, mechanism, factors affecting and applications of the various unit operations |
CO - 2 |
To appraise various laws governing the unit operations |
CO - 3 |
To understand the construction, working and application of Pharmaceutical Machinery |
CO - 4 |
To demonstrate the various pharmaceutically important processes and equipments. |
CO - 5 |
To understand the mechanism of Heat transfer. |
B.PHARM - YEAR - II (SEMESTER - IV) |
|
BP403T |
Physical Pharmaceutics II – Theory |
CO - 1 |
Relate various physicochemical properties of drug and excipient molecules in designing the dosage forms. |
CO - 2 |
Distinguish the principles of chemical kinetics & to use them for stability testing and determination of expiry date of formulations. |
CO - 3 |
Demonstrate the behavior and mechanism of drugs and excipients in the formulation development and evaluation of dosage forms. |
CO - 4 |
Understand the concept of rheology and its applications in pharmaceutical industries. |
CO - 5 |
Understanding the micromeritics and its applications in designing various drug delivery systems. |
BP407P |
Physical Pharmaceutics II – Practical |
CO - 1 |
Determine of particle size, particle size distribution, flow properties bulk density, true density and porosity using various methods |
CO - 2 |
Determine viscosity of liquids and semisolids by various methods. |
CO - 3 |
Determine sedimentation rate and sedimentation volume, Cloud and Kraft points of given surfactants, |
CO - 4 |
Determine reaction rate constant |
CO - 5 |
To carry out stability studies. |
YEAR - III (SEMESTER - V) |
|
BP502T |
Industrial Pharmacy I– Theory |
CO - 1 |
Carry out assessment of physicochemical properties of drugs as a tool in the optimization of solid and liquid dosage forms. |
CO - 2 |
Formulate and prepare tablets, capsules and liquid orals using established procedures and technology. |
CO - 3 |
Describe the facilities and standards necessary for the industrial production of sterile dosage forms. |
CO - 4 |
Formulate and prepare different types of parenteral and ophthalmic dosage forms |
CO - 5 |
Select and evaluate appropriate packaging materials for various pharmaceutical dosage forms. |
BP506P |
Industrial Pharmacy I – Practical |
CO - 1 |
Demonstrate the correct use of various equipment in pharmaceutics laboratory relevant to tablets, capsules, |
CO - 2 |
Demonstrate the correct use of various equipment in pharmaceutics laboratory relevant to parenteral, semisolids and pharmaceutical packaging material evaluation |
CO - 3 |
Explain formulation, evaluation and labeling of tablets & capsules, parenteral and semisolids as per regulatory requirements. |
CO - 4 |
Understand use of excipients in formulation of tablet, capsules, semisolids and parenteral preparations |
CO - 5 |
Perform evaluation of glass containers as per IP. |
B.PHARM - YEAR - III (SEMESTER - VI) |
|
BP604T |
Biopharmaceutics and Pharmacokinetics – Theory |
CO - 1 |
Understand the concept of bio pharmaceutics and its applications in formulation development |
CO - 2 |
Discuss various pharmacokinetic processes and their relevance in dosage form design. |
CO - 3 |
Design dosage regimens for patients based on calculated pharmacokinetic parameters. |
CO - 4 |
Select the correct pharmacokinetic model based on plasma level or urinary excretion data that best describes the process of drug absorption, distribution, metabolism and elimination (ADME). |
CO - 5 |
Calculate various pharmacokinetic parameters from plasma and urinary excretion data applying compartment modeling and model independent methods to describe the kinetics of drug absorption, distribution, metabolism, excretion or elimination |
B.PHARM - YEAR - III (SEMESTER - VI) |
|
BP605T |
Pharmaceutical Biotechnology – Theory |
CO - 1 |
Discuss the importance and Application of Immobilized enzymes. |
CO - 2 |
Understand concepts of recombinant DNA technology, genetic engineering, |
CO - 3 |
Describe the concept of immunity and production of vaccine. Explain production of Monoclonal antibodies |
CO - 4 |
Discuss various immune blotting techniques Knowledge about genetic multiplication and biotransformation |
CO - 5 |
Explain the process of Fermentation technology and its applications in production of pharmaceuticals. |
B.PHARM - YEAR - IV (SEMESTER - VII) |
|
BP702T |
Industrial Pharmacy II – Theory |
CO - 1 |
Discuss the process of pilot plant scale up of pharmaceutical dosage forms. |
CO - 2 |
Understand the process of technology transfer from lab scale to commercial batch |
CO - 3 |
Explain the different laws and acts that regulate pharmaceutical industry. |
CO - 4 |
Describe the approval process and regulatory requirements of drug products. |
CO - 5 |
Describe the organization and responsibilities of national and state licensing authority. |
B.PHARM - YEAR - IV (SEMESTER - VII) |
|
BP704T |
Novel Drug Delivery System – Theory |
CO - 1 |
Explain the principles and technology used in the design of sustained release and controlled release drug delivery systems |
CO - 2 |
Understand the criteria for selection of drugs and polymers for the development of Novel drug delivery systems. |
CO - 3 |
Understand the formulation, evaluation and applications of various novel drug delivery systems |
CO - 4 |
Explain the formulation and characterization of transdermal drug Delivery systems |
CO - 5 |
Discuss various approaches for the development of targeted drug Delivery |
B.PHARM - YEAR - IV (SEMESTER - VII) |
|
BP706PS |
Practice School |
CO - 1 |
To understand the importance of realistic learning through practice in various domains such as community pharmacy, drug testing and manufacturing, preclinical testing, clinical practice, patent filing, regulatory filing accounting, green audit and article writing. |
CO - 2 |
To get familiarize with the aspects of realistic practice in the domain of interest. |
CO - 3 |
To develop knowledge and skills related to practical learning in the domain of interest. |
CO - 4 |
To analyze the problems encountered during realistic practice and make use of theoretical knowledge to resolve those problems. |
CO - 5 |
To build up the ability to perform well in the domain of interest after becoming an employee/entrepreneur. |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP801T |
Biostatistics and Research Methodology |
CO - 1 |
Learn general research methodology |
CO - 2 |
Understand the basic concepts of biostatistics |
CO - 3 |
Learn different parametric and non-parametric tests |
CO - 4 |
Understand the functions of ethics committees in medical research |
CO - 5 |
Develop the ability to apply the methods while working on a research project work |
CO - 6 |
Describe the appropriate statistical methods required for a particular research design. |
CO - 7 |
Choose the appropriate research design and develop appropriate research hypothesis for a research project. |
CO - 8 |
Develop a appropriate framework for research studies. |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP803ET |
Pharma Marketing Management |
CO - 1 |
Describe the concept of pharmaceutical marketing. |
CO - 2 |
Enumerate the concept of product management in pharmaceutical industry |
CO - 3 |
Discuss the various components of promotion of pharmaceutical products |
CO - 4 |
Explain the different pharmaceutical marketing channels. Discuss the emerging concepts of marketing |
CO - 5 |
Discuss the roles and responsibilities of pricing authorities in India |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP804ET |
Pharmaceutical Regulatory Science |
CO - 1 |
To recall the concepts of Drug discovery, development process, clinical studies and generic drug product development. |
CO - 2 |
To perceive the regulatory approval process and timelines for IND, NDA and ANDA and to know about changes to an approved NDA/ANDA. |
CO - 3 |
To familiar with Regulatory authorities and agencies like India, USA, Europe, Australia, Japan and Canada. |
CO - 4 |
To know the regulatory registration process of Indian drugs in overseas market which include to understand about technical documents like DMF, CTD, eCTD and ACTD. |
CO - 5 |
To assimilate the process of clinical trials and pharmacovigilance as well as to understand obligations of GCP in clinical trials. |
CO - 6 |
To understand the concepts of Regulatory science in pharmaceutical industry as well as to make use of regulatory guidelines, laws, acts, orange and purple book. |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP807ET |
Computer Aided Drug Design |
CO - 1 |
The students can be able to recall the approaches in drug discovery, drug development, lead discovery based on metabolism and clinical observation and also analog based drug design |
CO - 2 |
Studied the development, approaches of QSAR, importance and determination of physicochemical parameters |
CO - 3 |
The students can be able to make use of molecular modeling and virtual screening techniques |
CO - 4 |
The students can be able to apply the molecular docking techniques to examine the binding interactions of ligand with molecular targets |
CO - 5 |
The students can be able to explain the applications of bioinformatics, chemo informatics, ADME databases, chemical, biochemical and pharmaceutical databases relevant to drug design |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP809ET |
Cosmetic Science |
CO - 1 |
Understand the concepts of cosmetics, cosmoceuticals and its classification. |
CO - 2 |
Describe the role of cosmetic excipients and building blocks in the formulation of cosmetics |
CO - 3 |
Understand the formulation and evaluation of different cosmetic products. |
CO - 4 |
Evaluate cosmetics for various physico-chemical properties. |
CO - 5 |
Design of cosmetics and cosmeceuticals that address the problems of dry skin, acne, dermatitis, prickly heat, wrinkles, blemishes, hair fall, Dandruff, body odour, bleeding gums, mouth odour, teeth discoloration and sensitive teeth. |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP812ET |
Dietary Supplements and Nutraceuticals |
CO - 1 |
Understand the need of supplements by the different group of people to maintain healthy life. |
CO - 2 |
Understand the outcome of deficiencies in dietary supplements. |
CO - 3 |
Appreciate the components in dietary supplements and the application. |
CO - 4 |
Appreciate the regulatory and commercial aspects of dietary supplements including health claims. |
B.PHARM - YEAR - IV (SEMESTER - VIII) |
|
BP813PW |
Project Work |
CO - 1 |
Know the source of literature and literature survey |
CO - 2 |
Able to design research protocol and carry out study as per design |
CO - 3 |
Can analyze and interpret research data using appropriate statistical tools |
CO - 4 |
Capable of writing scientific documents |
CO - 5 |
Developed tendency to work in group |
Publication
S.No | Tittle of Paper | Name of The Author | Name of the Journal | Year of publication | ISSN number |
---|---|---|---|---|---|
1 | Formulation And Evalution Of Aceclofenac Sustained Delease Matrix Tables | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2017 | 2456-8147 |
2 | Formulation And Evaluation Of Lornoxicam Dispersible Tablets | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2017 | 2456-8147 |
3 | Formulation And Evalution Of Oral Medicated Jellies Of Cyproheptadine Hcl | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
4 | Formulation And Evaluation Of Rosuvastatin Sustained Release Matrix Tablet | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
5 | Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Cefdinir Antibiotic | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
6 | Formulation And Evaluation Of Anti-Fungal Property Containing Fluconazole Gel | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
7 | Formulation And Evaluation Of Oral Disintegrating Tablets And Oral Disintegrating Films Of Lisinopril | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
8 | Formulation And Evalution Of Aceclofenac Sustained Delease Matrix Tables | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2017 | 2456-8147 |
9 | Formulation And Evaluation Of Ofloxacin Microsphere By Using Ethyl Cellulose As A Polymer At Different Ratio | Dr.S.Chandra | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
10 | Formulation And Evaluation Of Diclofenac Sodium Transdermal Patches | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2018 | 2277-7105 |
11 | Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2019 | 2277-7105 |
12 | Development Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
13 | Formulation And Evalution Studies Of Enteric Coated Tablet Containing Non-Steroidal Anti Inflammatory Diclofenac Sodium | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
14 | Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
15 | Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
16 | Design And Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Predisolone | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
17 | Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
18 | Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
19 | Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Nizatidine Anti Ulcer Drug | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
20 | Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
21 | Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
22 | An Review Of Transdermal Drug Delivery System | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
23 | A Review On Sustained Release Drug Delivery System | Dr.S.Chandra | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
24 | Formulation And Evaluation Of Sustained Release Bilayer Tablet Of Flupirtine Maleate | R.Suresh | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
25 | Formulation And Evaluation Of Ofloxacin Microsphere By Using Ethyl Cellulose As A Polymer At Different Ratio | R.Suresh | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
26 | Formulation And Evalution Of Oral Medicated Jellies Of Cyproheptadine Hcl | R.Suresh | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
27 | Formulation And Evaluation Of Rosuvastatin Sustained Release Matrix Tablet | R.Suresh | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
28 | Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Cefdinir Antibiotic | R.Suresh | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
29 | Formulation And Evaluation Of Anti Fungal Property Containing Fluconazole Gel | R.Suresh | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
30 | Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery | R.Suresh | World Journal Of Pharmaceutical Research | 2019 | 2277-7105 |
31 | Development Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride | R.Suresh | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
32 | Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum | R.Suresh | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
33 | Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration | R.Suresh | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
34 | Design And Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Predisolone | R.Suresh | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
35 | Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride | R.Suresh | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
36 | An Review Of Transdermal Drug Delivery System | R.Suresh | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
37 | A Review On Sustained Release Drug Delivery System | R.Suresh | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
38 | Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation | R.Suresh | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
39 | Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy | R.Suresh | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
40 | Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion | R.Suresh | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
41 | Formulation And Evaluation Of Sustained Release Bilayer Tablet Of Flupirtine Maleate | S.Sangeetha | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
42 | Formulation And Evaluation Of Ofloxacin Microsphere By Using Ethyl Cellulose As A Polymer At Different Ratio | S.Sangeetha | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
43 | Formulation And Evalution Of Oral Medicated Jellies Of Cyproheptadine Hcl | S.Sangeetha | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
44 | Formulation And Evaluation Of Rosuvastatin Sustained Release Matrix Tablet | S.Sangeetha | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
45 | Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Cefdinir Antibiotic | S.Sangeetha | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
46 | Formulation And Evaluation Of Anti Fungal Property Containing Fluconazole Gel | S.Sangeetha | International Journal Of Advanced Pharmaceutical Science | 2018 | 2456-8147 |
47 | Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery | S.Sangeetha | World Journal Of Pharmaceutical Research | 2019 | 2277-7105 |
48 | Formulation And Evalution Studies Of Enteric Coated Tablet Containing Non-Steroidal Anti Inflammatory Diclofenac Sodium | S.Sangeetha | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
49 | Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum | S.Sangeetha | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
50 | Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration | S.Sangeetha | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
51 | Design And Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Predisolone | S.Sangeetha | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
52 | Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride | S.Sangeetha | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
53 | An Review Of Transdermal Drug Delivery System | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
54 | A Review On Sustained Release Drug Delivery System | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
55 | Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
56 | Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Nizatidine Anti Ulcer Drug | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
57 | Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
58 | Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
59 | Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration | S.Sangeetha | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
60 | Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2019 | 2277-7105 |
61 | Development Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
62 | Formulation And Evalution Studies Of Enteric Coated Tablet Containing Non-Steroidal Anti Inflammatory Diclofenac Sodium | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
63 | Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
64 | Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
65 | Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
66 | Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Nizatidine Anti Ulcer Drug | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
67 | Development Of Nanomaterial Based Topical Drug Delivery System For Diabetic Retinopathy | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
68 | Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
69 | A Review On Sustained Release Drug Delivery System | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
70 | Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
71 | Formulation Evaluation Of Amlodipine Besylate Solid Dispersion | S.Kavibharathi | World Journal Of Pharmaceutical Research | 2021 | 2277-7105 |
72 | Formulation And Evaluation Of Oral Medicated Jellies Of Cyproheptadine Hcl | A.Sheik Alisha | International Journal Of Advanced Pharmaceutical Sciences | 2018 | 2456-8147 |
73 | Formulation And Evaluation Of Olfloxacin Microspheres By Using Ethyl Cellulose As A Polymers At Different Ratio | A.Sheik Alisha | International Journal Of Advanced Pharmaceutical Sciences | 2018 | 2456-8147 |
74 | Designs, Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Prednisolone | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2020 | 2277-7105 |
75 | Formulation Characterisation And In Vitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymers Concentration | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2019 | 2227-7105 |
76 | Formulation And Evaluation Studies Of Enteric Coated Tablets Containing Non-Steroidal Anti-Inflammatory Diclofenac Sodium | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2020 | 2227-7105 |
77 | Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2019 | 2227-7105 |
78 | Devilopment Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2019 | 2227-7105 |
79 | A Review On Sustained Release Drug Delivery System | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2020 | 2227-7105 |
80 | Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion | A.Sheik Alisha | World Journal Of Pharmaceutical Research | 2020 | 2227-7105 |
Lab Facility
INVITRO DISSOLUTION APPARATUS
UV SPECTROSCOPY
UV SPECTROSCOPY
SINGLE TABLET PUNCHING MACHINE
INVITRO DISSOLUTION APPARATUS
OINTMENT FILLING MACHINE
MOU
S.NO | Academic year | Organization with which MoU is signed Date of Signing | Date of Signing | MOU Duration |
---|---|---|---|---|
1 | 2018-2019 | COLUMBIA ASIA HOSPITAL, MYSURU | 30/10/2018 | 5 Years |
2 | 2019-2020 | ATOZETA HEALTH SOLUTIONS PVT. LTD | 01/10/2019 | 5 Years |
3 | 2019-2020 | FREEDOM CARE | 27/09/2019 | 5 Years |
4 | 2020-2021 | CLINOSOL RESEARCH PRIVATE LIMITED | 05/10/2020 | 5 Years |
4 | 2021-2022 | MAARUTHI MEDICAL CENTRE AND HOSPITALS,ERODE | 19/01/2021 | 5 Years |